The IBN SINA Pharmaceutical Industry PLC reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 2,161.14 million compared to BDT 2,162.58 million a year ago. Net income was BDT 184.51 million compared to BDT 186.07 million a year ago. Basic earnings per share from continuing operations was BDT 5.9.
For the six months, sales was BDT 4,616.12 million compared to BDT 4,527.84 million a year ago. Net income was BDT 329.04 million compared to BDT 327.88 million a year ago. Basic earnings per share from continuing operations was BDT 10.53 compared to BDT 10.49 a year ago.